Growth in the Biotechnology Industry and Innovations in Biologics Due to Patent Expiration has Propelled the Growth of the Cell Line Development Market in the North America Region!
- Vikas Kumar
- July 22, 2023
- HEALTHCARE, NEWS
- Cell Line Development Market
- 0 Comments
The rising advancements in gene editing technologies, a highly developed biotechnology industry, and favorable government policies and funding initiatives. For instance, Thermo Fisher Scientific made the announcement on March 25, 2021, that the Applied BioSystems Quant Studio 5 Dx Real-Time PCR System’s listing with the U.S. Food and Drug Administration (FDA) had been completed. The novel product enables assay developers and clinical laboratories to meet testing requirements and improve their molecular diagnostics workflows. Adding to this, the growing use of cell lines in regenerative medicine and the rising demand for biopharmaceuticals boost the growth of the market in the region.
Access sample report (including graphs, charts, and figures): https://univdatos.com/report/cell-line-development-market/get-a-free-sample-form.php?product_id=41799
Further, the North America Cell Line Development Market is expected to grow at a strong CAGR of 10.0% during the forecast period (2022-2028). North America is anticipated to emerge as the fastest-growing cell line development market primarily owing to the spur in demand for biopharmaceuticals in the U.S. and Canada coupled with an aging population and the rising prevalence of chronic diseases. Moreover, the biopharmaceutical industry is experiencing increased innovation and competition as a result of the expiration of biologics patents which is driving the development of new and improved cell lines for the production of biologics. For instance, in April 2022, Kite, a Gilead Company received US FDA approval for Yescarta (axicabtagene ciloleucel) CAR T-cell therapy for adult patients with large B-cell lymphoma that is refractory to first-line chemoimmunotherapy or that relapses within 12 months of first-line chemoimmunotherapy.
FIG. 1 North America Cell Line Development Market Revenue (2020-2028)- USD Mn
For a detailed analysis of the Global Cell Line Development Market browse through ; https://univdatos.com/report/cell-line-development-market
Based on cell line, the market is segmented into recombinant, hybridomas, continuous cell line, and primary cell line. Amongst these, the primary cell line is expected to grow with a significant CAGR during the forecast period. The increasing demand for high-quality cell lines for drug development and research is driving the primary cell culture market. Additionally, the rising adoption of primary cell lines for therapeutic proteins, manufacturing of vaccines, and increasing use of gene editing technologies, such as CRISPR/Cas9. For instance, the Edit-R CRISPRa Portfolio was introduced by zon Discovery Group in 2020. The Alter R CRISPRa Portfolio is an assortment of plasmids that utilizes CRISPR enactment (CRISPRa) innovation to turn on the statement of explicit qualities in mammalian cells.
By source, the market is segmented into mammalian cell line and non-mammalian cell line. Among these, the mammalian cell line captured the majority share of the cell line development market in 2021. The major share of cell line development can be attributed to the increasing use of monoclonal antibody sources derived from mammals and the production of high-quality cell lines for research and drug development the increasing demand for biopharmaceuticals has driven the growth of the mammalian cell line market.
Global Cell Line Development Market Segmentation
Market Insight, by Cell Line
· Recombinant
· Hybridomas
· Continuous Cell Line
· Primary Cell Line
Market Insights, by Product
· Reagent and Media
· Equipment
· Finished Cells
· Others
Market Insight, by Source
· Mammalian Cell Line
· Non-mammalian Cell Line
Market Insights, by Application
· Recombinant Protein Expression
· Hybridomas Technology
· Vaccine Production
· Drug Discovery
· Others
Market Insight, by Region
· North America
o U.S.
o Canada
o Rest of North America
· Europe
o Germany
o U.K.
o France
o Italy
o Spain
o Rest of Europe
· APAC
o China
o Japan
o India
o Rest of APAC
· Rest of the World
Top Company Profiles
· GE Healthcare
· Lonza
· Sartorious AG
· WuXi AppTec
· Merck KGaA
· Selexis SA
· Thermo Fisher Scientific Inc.
· Corning Incorporated
· Danaher
· ATCC
Related Posts
